Novo Nordisk A/S
NOVO B
ISIN DK0062498333 / Valor 129508879
Novo Nordisk A/S
UMushroom community rating:
About company
Novo Nordisk A/S is a global healthcare company founded in 1923 and based in Denmark. The company is known for its focus on diabetes care and has a long history of innovation in this field. The Novo Nordisk Way, which outlines the company's values and behaviors, is inspired by the vision of its founders to make a difference in diabetes treatment. Today, Novo Nordisk continues to be a leader in diabetes management, as well as in other areas of healthcare.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (20.08.2024):
Q1 2024 Revenue
Novo Nordisk A/S reported its financial results for the first quarter of 2024, showing a significant increase in revenue. The company achieved a total revenue of DKK 45 billion, marking a 12% growth compared to the same period in the previous year.
Q1 2024 Net Profit
In the first quarter of 2024, Novo Nordisk A/S's net profit rose to DKK 12 billion. This represents a 15% increase from the first quarter of 2023, driven by strong sales performance and cost management.
Q1 2024 Sales Performance
Novo Nordisk A/S experienced robust sales growth in the first quarter of 2024, particularly in its diabetes and obesity care segments. Sales in these areas grew by 14%, contributing significantly to the overall revenue increase.
Q1 2024 Earnings Per Share
The earnings per share (EPS) for Novo Nordisk A/S in the first quarter of 2024 were reported at DKK 5. This is an improvement from DKK 4.30 in the same quarter of the previous year, reflecting the company's strong financial performance.
Q1 2024 Dividend Announcement
Following the strong financial results for the first quarter of 2024, Novo Nordisk A/S announced an interim dividend of DKK 3 per share. This decision underscores the company's commitment to returning value to its shareholders.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
345274 M
Market cap (USD)
2,864,199
Daily traded volume (Shares)
742 / 718.5
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Daniela Gie
EQUITIES OF THE SAME SECTOR
